This is partly because the government and Danish Regions took the first steps in 2016 with a joint strategy for personalised medicine. Since then, collaboration between the healthcare service, the research community, patient organisations and universities has been strengthened. And in 2019, the Danish National Genome Center was established with support from the Novo Nordisk Foundation. The ambition was clear: to give up to 60,000 patients access to better diagnostics and treatment based on their genetic profile.
It’s a strong starting point that we are proud of. This has put Denmark on the world map and made us one of the leading countries in personalised medicine. We need it to stay that way.
Download 'Personalised medicine strategy 2025-2027'